Breaking News

You are here » Indian-Commodity  :  Investment  :  Dabur India plans to start an online platform for selling products: Report


Dabur India plans to start an online platform for selling products: Report

Dabur India is reportedly planning to start an online platform where it will sell products of other companies, along with its own. The platform is likely to go live next year. The fast-moving consumer goods (FMCG) major would sell ayuveda-based health care products, along with providing information on ailments and therapy.

Dabur India is one of the largest FMCG Company in India. Building on a legacy of quality and experience of over 125 years, Dabur operates in key consumer products categories like Hair Care, Oral Care, Health Care, Skin Care, Home Care & Foods.


Related News

View all news

Spice Mobility's arm to make investment in Fast Track IT Solutions

Spice Mobility's step down subsidiary -- S Global Services, Singapore, (SGIC) has decided to invest BDT233,333 in Fast Track IT Solutions, a private company limited by shares incorporated under the laws......

Alka Securities gets nod to initiate investment in consultancy partnership

Alka Securities has received an approval to initiate investment in a consultancy partnership. The Board of Directors of the company at their meeting held on November 14, 2018, approved the same and has......

Yes Bank acquires 30% stake in Valecha Investments

Yes Bank has acquired 2,30,655 equity shares, constituting 30.00% of the paid-up share capital, having nominal value of Rs 100 per share of Valecha Investments, pursuant to invocation of pledge on the......

Top News

View all news

Karnataka Bank launches CASA campaign

Karnataka Bank has launched Current & Savings Accounts campaign (CASA) of FY 2018-19 and introduced a new SB scheme 'KBL SB - TASC' a specialized product for Trusts/Associates/Societies/Clubs.Under......

M&M's arm opens manufacturing hub in Bengaluru

Mahindra & Mahindra's (M&M) subsidiary -- Mahindra Electric Mobility has opened its electric technology manufacturing hub set up with an investment of Rs 100 crore in Bengaluru. The plant......

Venus Remedies reports positive result in Phase-3 Clinical Trials for ELORES

Venus Remedies has reported positive Top-Line results in its Phase-3 Clinical Trials for its flagship product ELORES. The results were presented at IDWeek 2018 in San Francisco. IDWeek is an annual scientific......